← 검색으로

BDX

BECTON DICKINSON & CO

CIK: 0000010795 · Healthcare · Medical Instruments & Supplies

기간
149.43 USD
최근 종가 · 사전계산값
PER (TTM)
26.12
PER (Forward)
11.11
EPS (TTM)
-
EPS (Forward)
-
PBR
1.74
시가총액
41.17B
배당수익률
281.00%
베타
0.28
1개월 수익률
-3.88%
3개월 수익률
-8.92%
6개월 수익률
9.04%
1년 수익률
16.39%
2년 수익률
-
5일 평균거래량
4046920
60일 평균거래량
2891507
1년 평균거래량
2976221
5d/60d 거래량 비율
1.40×
60d/1y 거래량 비율
0.97×
변동성(60일, 연환산)
23.62%
BB 스퀴즈 스코어
1.05
SMA50 비율
0.95
SMA200 비율
0.98
RSI (14)
45
20일 수렴도
0.03
52주 최고
184.21
52주 최저
128.44
고점 대비
-18.88%
저점 대비
16.34%

펀더멘털 갱신: 2026-05-10T07:55:47+00:00 · 시세 갱신: 2026-05-10T06:11:31+00:00

회사 정보

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

섹터
Healthcare
산업
Medical Instruments & Supplies
본사
Franklin Lakes, United States
임직원
60,000명
웹사이트
bd.com